Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability
NCT07035964
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to evaluate the impact of 28-day supplementation with effera human lactoferrin, compared to a placebo control product on indicators of gut barrier health in males and females
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Gut Permeability
- Gut Health
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 40 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Helaina Inc.
- Last updated on ClinicalTrials.gov
- June 25, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- Biofortis Inc · Addison, IL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.